Julia Kronberger, BSc MSc
Winter term 2023
321113 PR Drug Synthesis - Laboratory Course - B7
Guarrochena, X., Kronberger, J., Tieber, M., Ciesielski, P., Mindt, T. L., & Feiner, I. V. J. (2024). Straightforward Synthesis of DFO* - An Octadentate Chelator for Zirconium-89. ChemMedChem, 19(3), [e202300495]. https://doi.org/10.1002/cmdc.202300495
Fuchs, V., Cseh, K., Hejl, M., Vician, P., Neuditschko, B., Meier-Menches, S. M., Janker, L., Bileck, A., Gajic, N., Kronberger, J., Schaier, M., Neumayer, S., Koellensperger, G., Gerner, C., Berger, W., Jakupec, M. A., Malarek, M. S., & Keppler, B. K. (2023). Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in Mice. Chemistry: A European Journal, 29(4), [e202202648]. https://doi.org/10.1002/chem.202202648
Evaluation of two albumin-targeting moieties as in situ binders in comparison to maleimide
Anja Federa (Speaker), H. Schueffl (Contributor), Alexander Kastner (Contributor), Julia Kronberger (Contributor), Bernhard Keppler (Contributor), Thomas Mindt (Contributor), P. Heffeter (Contributor) & Christian Kowol (Contributor)
3 Sep 2023
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Speaker), Thomas Mindt (Contributor), Elisabeth de Vries (Contributor) & Marie Brandt (Contributor)
12 May 2022
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Speaker), E. de Vries (Contributor), Marie Brandt (Contributor) & Thomas Mindt (Contributor)
5 Nov 2021
Activity: Talks and presentations › Talk or oral contribution › Science to Science